drugset / Trial / NCT00477373
Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To assess the efficacy of Di-valproate in Bipolar I patients suffering from a manic episode according to DSM IV (APA 1994) over a 12 weeks period of treatment. To evaluate the clinical safety of Di-valproate.
Timeline
- Start
- 2006-12
- Primary completion
- 2007-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Divalproate | Unknown | 500 mg | — |